Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News 186 Complaints Over Abbott’s Neurostimulator Revealed

186 Complaints Over Abbott’s Neurostimulator Revealed

18th September 2023

Abbott’s neurostimulator implant targets the deep brain, dorsal root ganglion, and spinal cord to address problems such as chronic discomfort.

The medical device was manufactured so it could be used safely in MRI scanning sessions, with an ‘MRI mode’ built in. However, a few people have discovered that once they make treatment stop, they are unable to resume it after.

From the end of 2015 through to mid-2023, more than 155,000 of these medical devices supplied to the US may have been impacted.

If a patient using the neurostimulator stops the connection, there is no way for them to reconnect with the implant and resume therapy; this requires a clinician programmer who had already been matched. But the individual may have to endure surgery to switch out the pulse generator if a formerly matched device is unavailable.

186 complaints regarding the issue and 73 reports of injury have been sent to Abbott.

Users are advised by Abbott to install the most recent edition of the app before engaging the MRI mode and to avoid disconnecting Bluetooth while in the mode. The most recent version of the app offers guidance on how to keep the Bluetooth connection. Connections should be retained by clinician programmers as a contingency.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips and straight to your inbox.